UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005602
Receipt number R000006621
Scientific Title The Effect of Rebamipide for the Patients with Reflux Esophagitis and Gastritis
Date of disclosure of the study information 2011/05/15
Last modified on 2016/06/05 15:09:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effect of Rebamipide for the Patients with Reflux Esophagitis and Gastritis

Acronym

Effect of Rebamipide

Scientific Title

The Effect of Rebamipide for the Patients with Reflux Esophagitis and Gastritis

Scientific Title:Acronym

Effect of Rebamipide

Region

Asia(except Japan)


Condition

Condition

Phase IV, multi-center, randomized, open-labeled, comparison study

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of rebamipide by investigating its symptomatic response in patients with reflux esophagitis and gastritis

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of a total symptom score after four-week administration of esomeprazole and rebamipide

Key secondary outcomes

The mean decrease in the total symptom score at 4 weeks since trial medicine, the change from baseline of reflux symptoms (heartburn and regurgitation), the proportion of patients with at least a 50% decrease in the symptoms score compared with their baseline score, and the proportion of patients reporting complete improvement of symptoms


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intervention group is treated by rebamipide and esomeprazole

Interventions/Control_2

Control group is treated by esomeprazole

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1) Adults aged over 20 years and less 70 years
2) Patients diagnosed as reflux esophagitis through esophagogastroduodenoscopy
3) Patients signing the informed consent document of this clinical study

Key exclusion criteria

1) Pregnant or lactating women, child bearing women not using a proper contraception
2) Patients with history of gastrointestinal surgery
3) Patients with gastric ulcer or duodenal ulcer
4) Patients with significant impairment in the heart, the lung, the blood or the endocrine system
5) Patients with psychiatric disorders or alcohol or drug addiction
6) Patients who are considered to be unsuitable by investigator(s) because of other reason

Target sample size

492


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Soo Heon Park

Organization

The Catholic University of Korea College of Medicine, Seoul, Korea.

Division name

Department of Internal Medicine

Zip code


Address

62, Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea

TEL

82-2-3779-1163

Email

psheon5132@naver.com


Public contact

Name of contact person

1st name
Middle name
Last name Su Jin Hong

Organization

Soonchunhyang University College of Medicine, Seoul, Korea

Division name

Department of Internal Medicine

Zip code


Address

1174 Jung-dong Wonmi-gu, Bucheon, Korea

TEL

82-32-621-5087

Homepage URL


Email

sjhong@schmc.ac.kr


Sponsor or person

Institute

Korean College of Helicobacter and Upper Gastrointestinal Research

Institute

Department

Personal name



Funding Source

Organization

NO

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Yeouido St. Mary's hospital (Seoul, Korea), Soonchunhyang University Bucheon Hospital(Bucheon, Korea), Chung-ang University Medical Center(Seoul, Korea), Seoul National University Bundang Hospital(Seongnam), Samsung Medical Center(Seoul, Korea), Inje University Seoul Paik Hospital(Seoul, Korea), Korea University Ansan Hospital(Ansan, Korea), Severance Hospital(Seoul, Korea), Hanyang University Hospital(Seoul, Korea), Kyung Hee University Hospital(Seoul, Korea), Hallym University Kangdong Sacred Heart Hospital(Seoul, Korea), Ruijin Hospital(China), 1st Affiliated Hospital of Anhui Meical University (China), 2nd Affiliated Hospital of Wenzhou Medical University (China), Tianjin General Hospital(China), Eastern Hospital (China), Siriraj Hospital of Mahidol University (Thailand), Cardinal Santos Medical Center (The Philippines)


Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 05 Month 15 Day

Date of IRB


Anticipated trial start date

2011 Year 11 Month 01 Day

Last follow-up date

2014 Year 04 Month 20 Day

Date of closure to data entry

2014 Year 04 Month 25 Day

Date trial data considered complete

2014 Year 05 Month 10 Day

Date analysis concluded

2014 Year 05 Month 15 Day


Other

Other related information



Management information

Registered date

2011 Year 05 Month 15 Day

Last modified on

2016 Year 06 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006621


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name